{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:23Z","timestamp":1772165903864,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess whether Sjogren\u2019s Syndrome (SS) is associated with outcomes after total knee or hip arthroplasty (TKA\/THA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used the 1998\u20132014\u2009U.S. National Inpatient Sample data. We performed multivariable-adjusted logistic regression analyses to assess the association of SS with healthcare utilization (hospital charges, length of hospital stay, discharge to non-home setting), and in-hospital complications (implant infection, revision, transfusion, mortality), controlling for important covariates and confounders. In sensitivity analyses, we additionally adjusted the main models for hospital location\/teaching status, bed size, and region\n                      <jats:bold>.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We examined 4,116,485 primary THAs and 8,127,282 primary TKAs performed from 1998 to 2014; 12,772 (0.2%) primary TKAs and 6222 (0.2%) primary THAs were done in people with SS. In multivariable-adjusted models, SS was associated with a statistically significant higher odds ratio (OR; 95% confidence interval (CI)) of discharge to a rehabilitation\/inpatient facility post-THA, 1.13 (1.00, 1.28), but not post-TKA, 0.93 (0.86, 1.02). We noted no differences in the length of hospital stay or hospital charges. SS was associated with significantly higher adjusted odds of in-hospital transfusion post-THA, 1.37 (1.22, 1.55) and post-TKA, 1.21 (1.10, 1.34). No significant differences by SS diagnosis were seen in hospital stay, hospital charges implant infection, implant revision or mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>People with SS had higher transfusion rate post-TKA\/THA, and higher rate of discharge to non-home setting post-THA. The lack of association of SS with post-arthroplasty complications should reassure patients, surgeons and policy-makers about the utility of TKA\/THA in people with SS undergoing these procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-020-03514-9","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T15:02:39Z","timestamp":1595689359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sjogren\u2019s syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"key":"3514_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3514_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/acr.21610","volume":"64","author":"AS Malladi","year":"2012","unstructured":"Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, et al. Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry. Arthritis Care Res (Hoboken). 2012;64:911\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3514_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-0825.2009.01582.x","volume":"15","author":"N Roescher","year":"2009","unstructured":"Roescher N, Tak PP, Illei GG. Cytokines in Sjogren's syndrome. Oral Dis. 2009;15:519\u201326.","journal-title":"Oral Dis"},{"key":"3514_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2106\/00004623-200405000-00012","volume":"86-A","author":"O Ethgen","year":"2004","unstructured":"Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004;86-A:963\u201374.","journal-title":"J Bone Joint Surg Am"},{"key":"3514_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-018-0008-9","volume":"2","author":"SM Goodman","year":"2018","unstructured":"Goodman SM, Bass AR. Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review. BMC Rheumatol. 2018;2:2.","journal-title":"BMC Rheumatol"},{"key":"3514_CR6","volume-title":"Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS). http:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp. Last modified 8\/13\/18","author":"HCUP Databases","year":"2018","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS). http:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp. Last modified 8\/13\/18. Rockville: Agency for Healthcare Research and Quality; 2018. [cited 2019 04\/26\/2019]."},{"key":"3514_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2106\/00004623-200409000-00008","volume":"86-A","author":"JN Katz","year":"2004","unstructured":"Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004;86-A:1909\u201316.","journal-title":"J Bone Joint Surg Am"},{"key":"3514_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3899\/jrheum.101149","volume":"38","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Linehan T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol. 2011;38:1612\u20136.","journal-title":"J Rheumatol"},{"key":"3514_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jvs.2008.05.010","volume":"48","author":"JK Giacovelli","year":"2008","unstructured":"Giacovelli JK, Egorova N, Nowygrod R, Gelijns A, Kent KC, Morrissey NJ. Insurance status predicts access to care and outcomes of vascular disease. J Vasc Surg. 2008;48:905\u201311.","journal-title":"J Vasc Surg"},{"key":"3514_CR10","first-page":"366","volume":"29","author":"GJ Young","year":"1992","unstructured":"Young GJ, Cohen BB. The process and outcome of hospital care for Medicaid versus privately insured hospital patients. Inquiry. 1992;29:366\u201371.","journal-title":"Inquiry"},{"key":"3514_CR11","first-page":"428","volume":"51","author":"PL Santaguida","year":"2008","unstructured":"Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN, Kreder HJ, et al. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg. 2008;51:428\u201336.","journal-title":"Can J Surg"},{"key":"3514_CR12","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1002\/art.37690","volume":"64","author":"B Ravi","year":"2012","unstructured":"Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012;64:3839\u201349.","journal-title":"Arthritis Rheum"},{"key":"3514_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00402-014-2101-x","volume":"134","author":"M Peltola","year":"2014","unstructured":"Peltola M, Jarvelin J. Association between household income and the outcome of arthroplasty: a register-based study of total hip and knee replacements. Arch Orthop Trauma Surg. 2014;134:1767\u201374.","journal-title":"Arch Orthop Trauma Surg"},{"key":"3514_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3514_CR15","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.arth.2016.03.045","volume":"31","author":"SM Kurtz","year":"2016","unstructured":"Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Which hospital and clinical factors drive 30- and 90-day readmission after TKA? J Arthroplast. 2016;31:2099\u2013107.","journal-title":"J Arthroplast"},{"key":"3514_CR16","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.arth.2016.03.041","volume":"31","author":"SM Kurtz","year":"2016","unstructured":"Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Hospital, patient, and clinical factors influence 30- and 90-day readmission after primary Total hip Arthroplasty. J Arthroplast. 2016;31:2130\u20138.","journal-title":"J Arthroplast"},{"key":"3514_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/ard.2007.071563","volume":"67","author":"A Hartkamp","year":"2008","unstructured":"Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Ann Rheum Dis. 2008;67:91\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3514_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","volume":"48","author":"JM Meijer","year":"2009","unstructured":"Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford). 2009;48:1077\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"3514_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87:210\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"3514_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sjogren's syndrome. Lancet. 2005;366:321\u201331.","journal-title":"Lancet"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03514-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-020-03514-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03514-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T19:28:30Z","timestamp":1627154910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03514-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3514"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03514-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.24230\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.24230\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Alabama at Birmingham\u2019s Institutional Review Board approved this study and all investigations were conducted in conformity with ethical principles of research (UAB X120207004). The IRB waived the need for an informed consent for this database study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no financial conflicts related directly to this study. JAS has received consultant fees from Crealta\/Horizon, Medisys, Fidia, UBM LLC, Trio health, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Spherix, Practice Point communications, the National Institutes of Health and the American College of Rheumatology. JAS owns stock options in Amarin pharmaceuticals and Viking therapeutics. JAS is on the speaker\u2019s bureau of Simply Speaking. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS served as a member of the American College of Rheumatology\u2019s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee. JDC has no conflicts. There are no non-financial competing interests for either author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"492"}}